Showing results (181-190 of 223) with videos related to

Sort By:
Pageof 23
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 22, 2024
Clinical impact of gender and age at onset on disease trajectory in primary progressive multiple sclerosis patientsSebastian Camerlingo, Fernando Rubinstein, Maria Celia Ysrraelit, et al.
Journal of the Neurological Sciences|August 11, 2018
Consensus recommendations for the diagnosis and treatment of primary progressive multiple sclerosis in Latin AmericaEdgardo Cristiano, Juan Ignacio Rojas, Patricio Abad, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 22, 2025
Artificial Intelligence-Based Virtual Assistant for the Diagnostic Approach of Chronic AtaxiasLucas Alessandro, Nicolas Bianciotti, Luciana Salama, et al.
Multiple Sclerosis and Related Disorders|May 28, 2025
Latin American RAND/UCLA modified Delphi consensus recommendations for management and treatment of adult MOGAD patients in clinical practiceEdgar Carnero Contentti, Jorge Correale, Juan I Rojas, et al.
Science (New York, N.Y.)|April 2, 2016
The TAM family receptor tyrosine kinase TYRO3 is a negative regulator of type 2 immunityPamela Y Chan, Eugenio A Carrera Silva, Dimitri De Kouchkovsky, et al.
The New England Journal of Medicine|August 7, 2020
Ofatumumab versus Teriflunomide in Multiple SclerosisStephen L Hauser, Amit Bar-Or, Jeffrey A Cohen, et al.
Multiple Sclerosis and Related Disorders|December 8, 2020
Usage trend of oral drugs for multiple sclerosis patients in ArgentinaRicardo Alonso, Orlando Garcea, María Barbara Eizaguirre, et al.
Multiple Sclerosis and Related Disorders|January 15, 2022
Evaluation of the times of disability progression and related factors in patients with primary progressive multiple sclerosis from ArgentinaRicardo Alonso, Orlando Garcea, Juan Ignacio Rojas, et al.
The Lancet. Neurology|July 21, 2023
Differential diagnosis of suspected multiple sclerosis: an updated consensus approachAndrew J Solomon, Georgina Arrambide, Wallace J Brownlee, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 26, 2023
Frequency of new asymptomatic MRI lesions during attacks and follow-up of patients with NMOSD in a real-world settingEdgar Carnero Contentti, Pablo A Lopez, Verónica Tkachuk, et al.
Pageof 23